Perpetual Ltd Has $55.46 Million Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Perpetual Ltd reduced its stake in Intuitive Surgical, Inc. by 14.9%, selling 17,866 shares and bringing its total holdings to 102,056 shares valued at approximately $55.46 million.
• Insider Gary S. Guthart sold 29,360 shares at an average price of $472.49, significantly reducing his ownership by 59.69% in a transaction totaling around $13.87 million.
• Intuitive Surgical's stock recently experienced a minor increase of 0.5% and has a market cap of approximately $156.24 billion, with analysts projecting a consensus price target of $595.95.

Perpetual Ltd lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 102,056 shares of the medical equipment provider's stock after selling 17,866 shares during the period. Perpetual Ltd's holdings in Intuitive Surgical were worth $55,458,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Chilton Capital Management LLC lifted its position in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after buying an additional 43 shares in the last quarter. Global Financial Private Client LLC lifted its position in Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the last quarter. Elite Financial Inc. purchased a new position in Intuitive Surgical during the 1st quarter valued at $26,000. LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical during the 1st quarter valued at about $30,000. Finally, TD Capital Management LLC grew its stake in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after acquiring an additional 45 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insiders Place Their Bets

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the company's stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts have commented on ISRG shares. Piper Sandler reaffirmed an "overweight" rating and issued a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Royal Bank Of Canada reiterated an "outperform" rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. BTIG Research upped their target price on shares of Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. Finally, Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Trading Up 0.7%

Shares of NASDAQ ISRG traded up $2.89 during midday trading on Friday, reaching $438.72. The company's stock had a trading volume of 3,756,410 shares, compared to its average volume of 2,373,186. The stock has a market capitalization of $157.27 billion, a price-to-earnings ratio of 65.19, a PEG ratio of 4.60 and a beta of 1.61. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock has a 50 day simple moving average of $476.64 and a 200-day simple moving average of $503.68.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the company posted $1.78 EPS. The company's revenue was up 21.4% compared to the same quarter last year. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.